IMV Inc. to Present at the Cowen and Company 39th Annual Health Care Conference
March 07 2019 - 6:05AM
Business Wire
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage
immuno-oncology company today announced that Pierre Labbé, IMV’s
Chief Financial Officer will present at the Cowen and Company 39th
Annual Health Care Conference, which will be held March 11-13, 2019
in Boston, MA.
IMV’s presentation details include:
- Date: Wednesday, March 13,
2019
- Time: 9:20 – 9:50 a.m. ET
- Location: Salon C, 4th Floor at
The Marriott Copley Hotel, Boston, MA
There will be a live webcast of IMV’s presentation accessible
thru the IMV website at: http://wsw.com/webcast/cowen52/imv/ and
the presentation will then be archived for 90 days afterwards. A
copy of the presentation will also be available in the Events &
Presentations section of IMV’s website: www.imv-inc.com.
About IMV
IMV Inc. is a clinical stage biopharmaceutical company dedicated
to making immunotherapy more effective, more broadly applicable,
and more widely available to people facing cancer and other serious
diseases. IMV is pioneering a new class of immunotherapies based on
the Company’s proprietary drug delivery platform. This patented
technology leverages a novel mechanism of action that enables the
programming of immune cells in vivo, which are aimed at
generating powerful new synthetic therapeutic capabilities. IMV’s
lead candidate, DPX-Survivac, is a T cell-activating immunotherapy
that combines the utility of the platform with a target: survivin.
IMV is currently assessing DPX-Survivac as a monotherapy in
advanced ovarian cancer, as well as a combination therapy in
multiple clinical studies with Merck. Connect
at www.imv-inc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190307005081/en/
Investor Relations:Marc Jasmin, IMV Senior Director,
Investor Relations and CommunicationsO: (902) 492-1819 ext : 1042M:
(514) 617-9481 E: mjasmin@imv-inc.com
Media:Andrea Cohen, Sam Brown Inc.T: (917) 209-7163
E: andreacohen@sambrown.com
IMV (TSX:IMV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMV (TSX:IMV)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about IMV Inc (Toronto Stock Exchange): 0 recent articles
More Imv News Articles